MedPath

A dermatological study to evaluate the skin care formulations (intensive eye cream) for skin like reduce dry & dehydrated lines, clears, brightens, smoothens and nourishes the eye area, brightens dark circles, improve under eye puffiness on healthy participants.

Not Applicable
Active, not recruiting
Conditions
The objective of study is to evaluate the Dermatological efficacy with skin care formulations (intensive eye cream) on healthy participants
Registration Number
CTRI/2022/07/044410
Lead Sponsor
Mountain Valley Springs India Pvt Ltd
Brief Summary

It is a single center, prospective study to evaluate efficacyand safety of skin care formulations (INTENSIVE EYE CREAM) in healthyvolunteers. This study will be conducted in compliance with applicable nationalregulations for post marketing requirement of cosmetic products with the aim ofidentifying or quantifying safety hazards relating to an authorized cosmeticproduct and is aligned with various guidelines and recommendations for goodpharmacovigilance practices for cosmetic products

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) Indian Male/Female subjects.
  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar etc) Between 20 to 65 years of age, with normal skin condition.
  • Written informed consent signed by the subject in line with applicable regulation of country.
Exclusion Criteria
  • Having refused to give her consent by not signing the consent form.
  • Taking part in another study liable to interfere with this study.
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis).
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
  • Having cutaneous hypersensitivity.
  • Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation will include assessment of local adverse events of redness, itching, rashes and burning sensations and any other local side effect and will be categorized non serious (based on severity grades, patterns, and causality) and serious adverse events. There will be two types of assessment, subject self-assessment and dermatological evaluation by study investigatorAssessment will be done at 30 min, 20 days and 40 days of application.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Qaaf Healthcare International

🇮🇳

South, DELHI, India

Qaaf Healthcare International
🇮🇳South, DELHI, India
Dr Esha Roy
Principal investigator
9254425442
dresharoy5@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.